Skip to main content

Full Schedule

Full Schedule

  • Wednesday, August 2, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome
  • 8:15 AM – 8:30 AM ET
    1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant Immunotherapy
  • 8:30 AM – 8:45 AM ET
    1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant Immunotherapy
  • 8:45 AM – 9:00 AM ET
    1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Discussion
  • 9:00 AM – 9:15 AM ET
    Break
  • 9:15 AM – 10:00 AM ET
    2 - Session 2: Special Topic on Gastric Cancer
  • 10:00 AM – 10:15 AM ET
    Break
  • 10:15 AM – 11:15 AM ET
    Non-CME Innvoation Theater
  • 11:15 AM – 11:30 AM ET
    Break
  • 11:30 AM – 11:45 AM ET
    Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined Immunotherapy
  • 11:45 AM – 12:00 PM ET
    Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
  • 12:00 PM – 12:15 PM ET
    Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC)
  • 12:15 PM – 12:30 PM ET
    Break
  • 12:30 PM – 1:15 PM ET
    4 - Session 4: Special Topic on Genomic Testing
  • 1:15 PM – 1:30 PM ET
    Break
  • 1:30 PM – 2:30 PM ET
    Non-CME Innvoation Theater
  • 2:30 PM – 2:45 PM ET
    Break
  • 2:45 PM – 3:30 PM ET
    5 - Session 5: Special Topic on ctDNA
  • 3:30 PM – 3:45 PM ET
    Break
  • 3:45 PM – 4:30 PM ET
    6 - Session 6: Integration of Supportive Care
  • 4:30 PM – 4:45 PM ET
    Break
  • 4:45 PM – 5:30 PM ET
    7 - Session 7: Perspectives on Clinical Trial Development in Anal Cancer